POSTER SESSION III
Tuesday, March 1, 2011   —  9:30 AM - 12:00 Noon
Exhibit Hall


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...




PULMONARY PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
268 TTF-1, Napsin A, p63, TRIM29, Desmoglein-3 and CK5: An Evaluation of Sensitivity and Specificity and Correlation of Tumor Grade for Lung Squamous Cell Carcinoma vs. Lung Adenocarcinoma. (1808)
D Tacha, C Yu, T Haas - Biocare Medical, LLC, Concord, CA; Mercy Health System, Janesville, WI
Add
269 High Frequency of Coexpression of Maspin with p63 and p53 in Squamous Cell Carcinoma but Not in Adenocarcinoma of the Lung. (1731)
B Choy, JJ Findeis-Hosey, F Li, L McMahon, Q Yang, H Xu - University of Rochester Medical Center, NY
Add
270 Comparison of Napsin A and TTF-1 Expression in Metastatic Carcinomas from Various Sites: An Immunohistochemical Study of 143 Cases. (1784)
S Mukhopadhyay, AL-A Katzenstein - State University of New York Upstate Medical University, Syracuse
Add
271 Diagnostic Utility of PAX8, Napsin A and TTF-1 in Discriminating Metastatic Carcinoma from Primary Adenocarcinoma of the Lung. (1823)
J Ye, O Hameed, JJ Findeis-Hosey, L Fan, F Li, LA McMahon, Q Yang, HL Wang, H Xu - University of Rochester Medical Center, NY; University of Alabama at Birmingham; Cedars-Sinai Medical Center, Los Angeles
Add
272 Utility of Napsin A and TTF-1 Dual Stain on Paired Cytology and Surgical Specimens in Lung Carcinoma. (1810)
B Thakral, K Saluja, L Liu - NorthShore University HealthSystem, Evanston Hospital, Evanston; University of Chicago Pritzker School of Medicine, Chicago, IL
Add
273 Evaluation of Napsin A, CK 5/6, p63, and TTF-1 in Adenocarcinoma (ACA) vs. Squamous Cell Carcinoma (SCC) of the Lung. (1818)
K Whithaus, J Fukuoka, JS Jagirdar - University of Texas Helth Science Center at San Antonio; University of Toyama, Japan
Add
274 Napsin A Expression in Sclerosing Hemangiomas of the Lung. (1800)
L Schmidt, J Myers, J McHugh - University of Michigan, Ann Arbor
Add
275 Expression of Napsin A in Carcinomas from Various Organs. (1827)
K Zhang, H Liu, S Zhu, M Wilkerson, F Lin - Geisinger Medical Center, Danville, PA
Add
276 Validation of Napsin A/TTF-1 Double Stain in Adenocarcinoma of the Lung Versus Malignant Mesothelioma. (1764)
A Khoor, C Cortese, PT Cagle - Mayo Clinic, Jacksonville, FL; The Methodist Hospital, Houston, TX
Add
277 Association of NF2 Loss and MTOR Pathway Activation in Pleural Mesothelioma: Comprehensive Genetic Analysis of NF2 and Immunohistochemistry in 13 Cell Lines and 53 Tumors. (1727)
M Brevet, M Bott, Q Zhou, V Rusch, M Ladanyi - Memorial Sloan-Kettering Cancer Center, New York, NY
Add
278 Patterns of Metastases to N2 Lymph Nodes from Biphasic Pleural Malignant Mesothelioma. (1780)
MG McIntire, WG Richards, DJ Sugarbaker, LR Chirieac - Caris Life Sciences, Newton, MA; Brigham and Women's Hospital, Boston, MA
Add
279 Pattern of Spread to N2 Lymph Nodes Predicts Survival in Patients with Biphasic Pleural Malignant Mesothelioma. (1779)
MG McIntire, WG Richards, DJ Sugarbaker, LR Chirieac - Caris Life Sciences, Newton, MA; Brigham and Women's Hospital, Boston, MA
Add
280 Cytologic Grading Is an Independent Prognostic Factor in Epithelioid Diffuse Malignant Pleural Mesothelioma. (1760)
K Kadota, K Suzuki, C Sima, VW Rusch, PS Adusumilli, WD Travis - Memorial Sloan-Kettering Cancer Center, New York, NY
Add
281 Prognostic Value of Ki-67 Proliferative Index in Diffuse Malignant Mesothelioma. (1830)
W Zhang, M McIntire, R Bueno, J Godleski, L Chirieac - Brigham and Women's Hospital, Boston, MA; Caris Life Science, Newton, MA
Add
282 Prognostic Significance of Histological Subtypes, and Calretinin, Mesothelin, p16 and p53 Expression in Pleural Malignant Mesothelioma: A Study of 311 Cases from the MESOPATH IM@EC Center. (1746)
F GalateauSalle, N Le Stang, M Paciencia, C Drougard, - V Abonnet, Chu Caen, France
Add
283 Prognostic Significance of Tumor Chronic Inflammatory Infiltrate in Diffuse Malignant Mesothelioma. (1832)
W Zhang, M McIntire, R Bueno, J Godleski, L Chirieac - Brigham and Women's Hospital, Boston, MA; Caris Life Science, Newton, MA
Add
284 PET/CT in Pleural Mesothelioma after Talc Pleurodesis and Induction Chemotherapy: Histologic Findings at Hot and Cold Spots. (1805)
A Soltermann, P Kestenholz, H Moch, W Weder, H Steinert - University Hospital Zurich, Switzerland
Add
285 Pleuropulmonary Synovial Sarcoma: Analysis of 15 Cases with FISH and TLE-1. (1776)
SL Lino-Silva, JP Flores-Gutierrez, N Vilches-Cisneros, HR Dominguez-Malagon - Instituto Nacional de Cancerologia, Mexico, DF, Mexico; Hospital Universitario UANL, Monterrey, NL, Mexico
Add